Clinical Trials Logo

Clinical Trial Summary

Endoscopic retrograde cholangiopancreatography (ERCP) procedure is frequently encountered in non-operating room anesthesia applications (NORA). It is a procedure that requires deep sedation and analgesia in terms of gastroenterologist and patient comfort. Dexmedetomidine, which is increasingly used in NORA applications, comes to the fore because it does not cause respiratory depression, reduces the stress response, and provides hemodynamic stability. This study aims to compare the effects of dexmedetomidine-propofol (DP) and remifentanil-propofol (RP) combinations on hemodynamic stability, rapid recovery, and patient comfort in patients who underwent ERCP.


Clinical Trial Description

n/a


Study Design


NCT number NCT06403670
Study type Interventional
Source Baskent University Ankara Hospital
Contact
Status Completed
Phase Phase 4
Start date December 17, 2022
Completion date April 30, 2024